@article{lebret:hal-04195182,
TITLE = {Artificial intelligence to improve cytology performance in urothelial carcinoma diagnosis: results from validation phase of the French, multicenter, prospective VISIOCYT1 trial},
AUTHOR = {Lebret, Thierry and Paoletti, Xavier and Pignot, G{\'e}raldine and Roumigui{\'e},
Mathieu and Colombel, Marc C. and Savareux, Laurent and Verhoest, Gr{\'e}gory and Guy, Laurent and Rigaud, J{\'e}r{\^o}me and de Vergie, St{\'e}phane and Poinas, Gr{\'e}goire and Droupy, St{\'e}phane J. and Kleinclauss, Fran{\c c}ois M. and Courtade-Sa{\"i}di, Monique M. and Piaton, {\'E}ric and Radulescu, Cam{\'e}lia and Rioux-Leclercq, Nathalie C. and Kandel-Aznar, Christine and Renaudin, Karine and Cochand-Priollet, Bȩatrix and Allory, Yves and Nivet, S{\'e}bastien and Roupr{\^e}t, Morgan},
URL = {https://hal.science/hal-04195182},
JOURNAL = {World Journal of Urology},
PUBLISHER = {Springer Verlag},
VOLUME = {41},
PAGES = {2381--2388},
YEAR = {2023},
DOI = {10.1007/s00345-023-04519-4},
KEYWORDS = {Artificial intelligence ; Bladder ; Cancer ; Deep learning ; Markers ; Urothelial},
HAL_ID = {hal-04195182},
HAL_VERSION = {v1},
}